ArticleMolecular therapy : the journal of the American Society of Gene Therapy2011

AAV6-mediated systemic shRNA delivery reverses disease in a mouse model of facioscapulohumeral muscular dystrophy.

Sergia Bortolanza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.